Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Baroreflex | 23 | 2019 | 84 | 3.810 |
Why?
|
Prenatal Exposure Delayed Effects | 12 | 2019 | 88 | 2.530 |
Why?
|
Betamethasone | 9 | 2019 | 52 | 2.370 |
Why?
|
Heart Rate | 26 | 2020 | 315 | 2.350 |
Why?
|
Blood Pressure | 28 | 2022 | 804 | 2.220 |
Why?
|
Autonomic Nervous System | 10 | 2020 | 42 | 2.120 |
Why?
|
Angiotensin I | 16 | 2019 | 262 | 2.070 |
Why?
|
Hypertension | 16 | 2022 | 906 | 1.990 |
Why?
|
Peptide Fragments | 16 | 2019 | 422 | 1.970 |
Why?
|
Medulla Oblongata | 6 | 2019 | 53 | 1.620 |
Why?
|
Glucocorticoids | 8 | 2019 | 149 | 1.470 |
Why?
|
Oxidative Stress | 3 | 2019 | 223 | 1.340 |
Why?
|
Orthostatic Intolerance | 5 | 2019 | 10 | 1.140 |
Why?
|
Hemodynamics | 2 | 2019 | 148 | 1.010 |
Why?
|
Renin-Angiotensin System | 9 | 2019 | 182 | 0.940 |
Why?
|
Pregnancy | 17 | 2019 | 815 | 0.910 |
Why?
|
Peptidyl-Dipeptidase A | 5 | 2013 | 142 | 0.880 |
Why?
|
Nonverbal Communication | 2 | 2012 | 4 | 0.860 |
Why?
|
Empathy | 2 | 2012 | 17 | 0.830 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2019 | 100 | 0.800 |
Why?
|
Animals | 32 | 2022 | 7297 | 0.760 |
Why?
|
Female | 38 | 2022 | 18164 | 0.710 |
Why?
|
Inositol | 1 | 2019 | 5 | 0.710 |
Why?
|
Choline | 1 | 2019 | 14 | 0.710 |
Why?
|
Benzimidazoles | 4 | 2019 | 33 | 0.680 |
Why?
|
Tetrazoles | 4 | 2019 | 71 | 0.670 |
Why?
|
Male | 43 | 2022 | 17807 | 0.670 |
Why?
|
Pre-Eclampsia | 1 | 2019 | 53 | 0.670 |
Why?
|
Inflammation Mediators | 1 | 2019 | 101 | 0.670 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 4 | 2019 | 68 | 0.660 |
Why?
|
Kidney Tubules, Proximal | 2 | 2008 | 39 | 0.620 |
Why?
|
Angiotensin II | 10 | 2018 | 279 | 0.610 |
Why?
|
Sympathetic Nervous System | 4 | 2019 | 29 | 0.610 |
Why?
|
Nitrates | 1 | 2017 | 25 | 0.600 |
Why?
|
Antihypertensive Agents | 4 | 2019 | 339 | 0.580 |
Why?
|
Angiotensins | 5 | 2018 | 49 | 0.580 |
Why?
|
Sheep | 10 | 2018 | 221 | 0.570 |
Why?
|
Adrenal Cortex Hormones | 4 | 2019 | 148 | 0.560 |
Why?
|
Renin | 6 | 2019 | 112 | 0.550 |
Why?
|
Exercise | 2 | 2019 | 591 | 0.550 |
Why?
|
Dietary Supplements | 1 | 2017 | 170 | 0.550 |
Why?
|
Premature Birth | 4 | 2019 | 39 | 0.540 |
Why?
|
Therapeutic Touch | 2 | 2012 | 10 | 0.530 |
Why?
|
Meditation | 2 | 2012 | 22 | 0.530 |
Why?
|
Allopurinol | 1 | 2014 | 6 | 0.520 |
Why?
|
Nausea | 4 | 2018 | 49 | 0.510 |
Why?
|
Proteinuria | 1 | 2014 | 57 | 0.510 |
Why?
|
Rats | 13 | 2019 | 1604 | 0.500 |
Why?
|
Infant, Very Low Birth Weight | 6 | 2019 | 47 | 0.490 |
Why?
|
Citalopram | 1 | 2014 | 5 | 0.490 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2014 | 10 | 0.490 |
Why?
|
Brain Chemistry | 1 | 2014 | 30 | 0.490 |
Why?
|
Disease Models, Animal | 9 | 2019 | 980 | 0.480 |
Why?
|
Depressive Disorder, Major | 1 | 2014 | 35 | 0.480 |
Why?
|
Fetal Development | 3 | 2018 | 25 | 0.470 |
Why?
|
Kidney | 7 | 2023 | 485 | 0.470 |
Why?
|
Age Factors | 7 | 2020 | 1108 | 0.470 |
Why?
|
Adolescent | 17 | 2023 | 3254 | 0.450 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 172 | 0.450 |
Why?
|
Vasopressins | 4 | 2018 | 17 | 0.440 |
Why?
|
Time | 1 | 2012 | 21 | 0.430 |
Why?
|
Heart Failure | 2 | 2017 | 568 | 0.430 |
Why?
|
Touch | 1 | 2012 | 35 | 0.420 |
Why?
|
Heart | 3 | 2020 | 161 | 0.420 |
Why?
|
Infant, Premature | 4 | 2019 | 62 | 0.420 |
Why?
|
Temporal Lobe | 3 | 2017 | 41 | 0.410 |
Why?
|
Vagus Nerve | 4 | 2019 | 29 | 0.410 |
Why?
|
Humans | 34 | 2023 | 29093 | 0.410 |
Why?
|
Tilt-Table Test | 5 | 2018 | 13 | 0.400 |
Why?
|
Postural Orthostatic Tachycardia Syndrome | 3 | 2015 | 8 | 0.400 |
Why?
|
Rats, Sprague-Dawley | 9 | 2019 | 747 | 0.380 |
Why?
|
Gestational Age | 5 | 2019 | 96 | 0.380 |
Why?
|
Behavior, Animal | 1 | 2011 | 264 | 0.350 |
Why?
|
Receptor, Angiotensin, Type 1 | 4 | 2013 | 75 | 0.330 |
Why?
|
Allostasis | 3 | 2017 | 11 | 0.330 |
Why?
|
Sex Factors | 6 | 2019 | 631 | 0.320 |
Why?
|
Rats, Transgenic | 6 | 2019 | 52 | 0.320 |
Why?
|
Solitary Nucleus | 3 | 2015 | 34 | 0.310 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2017 | 43 | 0.300 |
Why?
|
Pilot Projects | 5 | 2019 | 469 | 0.280 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2019 | 34 | 0.280 |
Why?
|
Brain | 5 | 2019 | 930 | 0.280 |
Why?
|
Proto-Oncogene Proteins | 2 | 2019 | 90 | 0.270 |
Why?
|
Hydrocortisone | 2 | 2019 | 61 | 0.270 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2019 | 89 | 0.270 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2005 | 10 | 0.270 |
Why?
|
Infant, Newborn | 7 | 2023 | 598 | 0.250 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2023 | 27 | 0.230 |
Why?
|
Pressoreceptors | 1 | 2003 | 6 | 0.230 |
Why?
|
Anti-Infective Agents | 1 | 2023 | 43 | 0.230 |
Why?
|
Fludrocortisone | 2 | 2014 | 5 | 0.230 |
Why?
|
Cyclosporine | 1 | 2003 | 34 | 0.230 |
Why?
|
Sodium, Dietary | 1 | 2022 | 24 | 0.220 |
Why?
|
Dyspepsia | 1 | 2022 | 1 | 0.220 |
Why?
|
Child | 6 | 2019 | 2219 | 0.220 |
Why?
|
Neprilysin | 4 | 2013 | 32 | 0.210 |
Why?
|
Relaxation | 2 | 2012 | 9 | 0.210 |
Why?
|
Gastroparesis | 1 | 2022 | 10 | 0.210 |
Why?
|
Immunosuppressive Agents | 1 | 2003 | 167 | 0.200 |
Why?
|
Sheep, Domestic | 2 | 2019 | 18 | 0.200 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2019 | 37 | 0.200 |
Why?
|
Drug Design | 2 | 2019 | 44 | 0.200 |
Why?
|
Up-Regulation | 2 | 2019 | 183 | 0.190 |
Why?
|
Angiotensinogen | 2 | 2019 | 73 | 0.190 |
Why?
|
Piperidines | 2 | 2019 | 125 | 0.190 |
Why?
|
Cardiovascular Diseases | 2 | 2018 | 1013 | 0.190 |
Why?
|
Fetus | 2 | 2019 | 78 | 0.180 |
Why?
|
Case-Control Studies | 2 | 2019 | 859 | 0.180 |
Why?
|
Sodium Chloride, Dietary | 2 | 2022 | 29 | 0.180 |
Why?
|
Saliva | 1 | 2019 | 36 | 0.180 |
Why?
|
Acoustic Stimulation | 2 | 2017 | 125 | 0.180 |
Why?
|
Supine Position | 1 | 2019 | 9 | 0.180 |
Why?
|
Patient Positioning | 1 | 2019 | 21 | 0.180 |
Why?
|
Prenatal Care | 1 | 2019 | 46 | 0.170 |
Why?
|
Free Radical Scavengers | 1 | 2019 | 11 | 0.170 |
Why?
|
Aging | 3 | 2015 | 881 | 0.170 |
Why?
|
Enzyme Activation | 1 | 2019 | 126 | 0.170 |
Why?
|
Organophosphorus Compounds | 1 | 2019 | 35 | 0.170 |
Why?
|
Acetylcholine | 1 | 2019 | 47 | 0.170 |
Why?
|
Insulin Resistance | 1 | 2022 | 449 | 0.170 |
Why?
|
Physical Fitness | 1 | 2019 | 119 | 0.170 |
Why?
|
Homeostasis | 1 | 2019 | 127 | 0.170 |
Why?
|
Continental Population Groups | 1 | 2019 | 221 | 0.160 |
Why?
|
2,2'-Dipyridyl | 1 | 2017 | 2 | 0.160 |
Why?
|
Fungi | 1 | 2017 | 5 | 0.160 |
Why?
|
Electroencephalography | 1 | 2017 | 71 | 0.160 |
Why?
|
Edema | 1 | 2017 | 30 | 0.150 |
Why?
|
Metabolic Diseases | 1 | 2017 | 17 | 0.150 |
Why?
|
Nitrites | 1 | 2017 | 20 | 0.150 |
Why?
|
Antifungal Agents | 1 | 2017 | 33 | 0.150 |
Why?
|
Beta vulgaris | 1 | 2017 | 11 | 0.150 |
Why?
|
Physical Endurance | 1 | 2017 | 31 | 0.150 |
Why?
|
Bacteria | 1 | 2017 | 45 | 0.150 |
Why?
|
Young Adult | 3 | 2014 | 2402 | 0.150 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 71 | 0.150 |
Why?
|
Military Personnel | 1 | 2017 | 85 | 0.140 |
Why?
|
Overweight | 1 | 2018 | 256 | 0.140 |
Why?
|
Mental Health | 2 | 2020 | 104 | 0.140 |
Why?
|
Oxygen | 1 | 2017 | 139 | 0.140 |
Why?
|
Birth Weight | 3 | 2023 | 39 | 0.140 |
Why?
|
Hypotension, Orthostatic | 1 | 2015 | 10 | 0.140 |
Why?
|
Cognition | 1 | 2020 | 526 | 0.140 |
Why?
|
Aldosterone | 1 | 2015 | 28 | 0.140 |
Why?
|
Catecholamines | 1 | 2015 | 17 | 0.140 |
Why?
|
Syncope | 1 | 2015 | 24 | 0.140 |
Why?
|
Dominance, Cerebral | 1 | 2015 | 11 | 0.130 |
Why?
|
Inflammation | 1 | 2019 | 507 | 0.130 |
Why?
|
Adult | 5 | 2017 | 8420 | 0.130 |
Why?
|
Alzheimer Disease | 1 | 2019 | 312 | 0.130 |
Why?
|
Neurons | 1 | 2019 | 394 | 0.130 |
Why?
|
Antimetabolites | 1 | 2014 | 10 | 0.130 |
Why?
|
Endocannabinoids | 1 | 2015 | 34 | 0.130 |
Why?
|
Vascular Diseases | 1 | 2015 | 61 | 0.130 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2015 | 48 | 0.130 |
Why?
|
Fructose | 1 | 2014 | 9 | 0.130 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 285 | 0.130 |
Why?
|
Rats, Wistar | 1 | 2014 | 84 | 0.130 |
Why?
|
Resistance Training | 1 | 2015 | 70 | 0.130 |
Why?
|
Stroke Volume | 1 | 2017 | 278 | 0.130 |
Why?
|
Mineralocorticoids | 1 | 2014 | 4 | 0.130 |
Why?
|
Analysis of Variance | 5 | 2016 | 454 | 0.130 |
Why?
|
Stomach Diseases | 1 | 2014 | 7 | 0.130 |
Why?
|
Prospective Studies | 4 | 2023 | 2019 | 0.130 |
Why?
|
Caloric Restriction | 1 | 2015 | 92 | 0.120 |
Why?
|
Middle Aged | 5 | 2022 | 10829 | 0.120 |
Why?
|
Abdominal Pain | 1 | 2014 | 40 | 0.120 |
Why?
|
Gene Expression Regulation | 3 | 2015 | 481 | 0.120 |
Why?
|
Choroid Plexus | 1 | 2013 | 3 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 1379 | 0.110 |
Why?
|
Anxiety | 1 | 2014 | 159 | 0.110 |
Why?
|
North Carolina | 4 | 2018 | 1423 | 0.110 |
Why?
|
Reading | 1 | 2012 | 5 | 0.110 |
Why?
|
Love | 1 | 2012 | 4 | 0.110 |
Why?
|
Respiratory Rate | 1 | 2012 | 12 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 641 | 0.110 |
Why?
|
Psychophysiology | 1 | 2011 | 2 | 0.110 |
Why?
|
Depression | 1 | 2015 | 380 | 0.110 |
Why?
|
Extremities | 1 | 2012 | 48 | 0.110 |
Why?
|
Rest | 1 | 2012 | 49 | 0.110 |
Why?
|
Nitric Oxide | 2 | 2011 | 116 | 0.110 |
Why?
|
Animals, Newborn | 1 | 2012 | 111 | 0.100 |
Why?
|
Animals, Suckling | 1 | 2011 | 4 | 0.100 |
Why?
|
Sucking Behavior | 1 | 2011 | 4 | 0.100 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2011 | 11 | 0.100 |
Why?
|
Hydronephrosis | 1 | 2011 | 12 | 0.100 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2011 | 22 | 0.100 |
Why?
|
Kidney Medulla | 1 | 2011 | 29 | 0.100 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 1356 | 0.100 |
Why?
|
Receptors, Angiotensin | 1 | 2011 | 77 | 0.100 |
Why?
|
Hypotension | 1 | 2011 | 47 | 0.100 |
Why?
|
Anti-Inflammatory Agents | 1 | 2011 | 90 | 0.100 |
Why?
|
Time Factors | 4 | 2020 | 2001 | 0.090 |
Why?
|
Blotting, Western | 2 | 2012 | 281 | 0.090 |
Why?
|
Aged | 3 | 2020 | 9487 | 0.090 |
Why?
|
Glomerular Filtration Rate | 2 | 2023 | 287 | 0.090 |
Why?
|
Body Mass Index | 3 | 2018 | 865 | 0.090 |
Why?
|
Neurotransmitter Agents | 1 | 2010 | 26 | 0.090 |
Why?
|
Reactive Oxygen Species | 3 | 2019 | 158 | 0.090 |
Why?
|
Leptin | 1 | 2009 | 66 | 0.090 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2009 | 23 | 0.090 |
Why?
|
Exercise Test | 2 | 2019 | 194 | 0.080 |
Why?
|
Follow-Up Studies | 3 | 2019 | 2108 | 0.080 |
Why?
|
Treatment Outcome | 2 | 2015 | 3099 | 0.080 |
Why?
|
Obesity | 1 | 2015 | 1063 | 0.080 |
Why?
|
Microinjections | 3 | 2015 | 33 | 0.080 |
Why?
|
Fetal Organ Maturity | 2 | 2016 | 7 | 0.070 |
Why?
|
Epinephrine | 2 | 2017 | 41 | 0.070 |
Why?
|
Iodine Radioisotopes | 1 | 2006 | 18 | 0.070 |
Why?
|
C-Reactive Protein | 2 | 2017 | 232 | 0.070 |
Why?
|
RNA, Messenger | 3 | 2015 | 514 | 0.070 |
Why?
|
Norepinephrine | 2 | 2017 | 73 | 0.070 |
Why?
|
Risk Factors | 3 | 2019 | 3531 | 0.070 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 134 | 0.070 |
Why?
|
Receptor, Muscarinic M2 | 1 | 2005 | 1 | 0.070 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2005 | 9 | 0.070 |
Why?
|
Fasting | 1 | 2005 | 93 | 0.060 |
Why?
|
Heparin | 1 | 2005 | 75 | 0.060 |
Why?
|
Mice | 3 | 2019 | 2368 | 0.060 |
Why?
|
European Continental Ancestry Group | 2 | 2019 | 1131 | 0.060 |
Why?
|
Testosterone | 1 | 2003 | 47 | 0.060 |
Why?
|
Chronic Disease | 2 | 2014 | 369 | 0.050 |
Why?
|
Sodium | 1 | 2022 | 37 | 0.050 |
Why?
|
Kidney Cortex | 1 | 2022 | 25 | 0.050 |
Why?
|
Gastric Emptying | 1 | 2022 | 4 | 0.050 |
Why?
|
Cohort Studies | 2 | 2016 | 1687 | 0.050 |
Why?
|
Water | 1 | 2022 | 50 | 0.050 |
Why?
|
Papio | 1 | 2022 | 87 | 0.050 |
Why?
|
Signal Transduction | 2 | 2019 | 666 | 0.050 |
Why?
|
African Americans | 2 | 2019 | 1373 | 0.050 |
Why?
|
Macaca fascicularis | 1 | 2022 | 389 | 0.050 |
Why?
|
Diet | 1 | 2022 | 354 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2022 | 208 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2020 | 3717 | 0.050 |
Why?
|
Asian Continental Ancestry Group | 1 | 2019 | 110 | 0.040 |
Why?
|
Reference Values | 2 | 2010 | 224 | 0.040 |
Why?
|
Semicarbazides | 1 | 2019 | 1 | 0.040 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2019 | 2 | 0.040 |
Why?
|
PC12 Cells | 1 | 2019 | 7 | 0.040 |
Why?
|
Random Allocation | 2 | 2010 | 213 | 0.040 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2019 | 15 | 0.040 |
Why?
|
Triazoles | 1 | 2019 | 14 | 0.040 |
Why?
|
Drug Combinations | 1 | 2019 | 86 | 0.040 |
Why?
|
Cholinesterase Inhibitors | 1 | 2019 | 29 | 0.040 |
Why?
|
Cardiovascular System | 1 | 2019 | 39 | 0.040 |
Why?
|
Neuropsychological Tests | 1 | 2020 | 379 | 0.040 |
Why?
|
Memory | 1 | 2020 | 187 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2010 | 532 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2019 | 3111 | 0.040 |
Why?
|
Placenta | 1 | 2019 | 63 | 0.040 |
Why?
|
Creatinine | 1 | 2018 | 174 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2017 | 33 | 0.040 |
Why?
|
Interleukin-10 | 1 | 2017 | 30 | 0.040 |
Why?
|
Cell Line | 1 | 2019 | 449 | 0.040 |
Why?
|
Health Status | 1 | 2020 | 368 | 0.040 |
Why?
|
Molecular Structure | 1 | 2017 | 53 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 2017 | 29 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2017 | 82 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 1 | 2017 | 55 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2019 | 720 | 0.040 |
Why?
|
Veterans | 1 | 2017 | 50 | 0.040 |
Why?
|
Mitochondria | 1 | 2019 | 174 | 0.040 |
Why?
|
Uric Acid | 1 | 2017 | 24 | 0.040 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 68 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2017 | 225 | 0.040 |
Why?
|
Linear Models | 1 | 2017 | 426 | 0.030 |
Why?
|
Odds Ratio | 1 | 2017 | 447 | 0.030 |
Why?
|
Prognosis | 1 | 2020 | 1362 | 0.030 |
Why?
|
Myocardial Ischemia | 1 | 2016 | 83 | 0.030 |
Why?
|
Cholesterol | 1 | 2017 | 229 | 0.030 |
Why?
|
Elasticity | 1 | 2015 | 34 | 0.030 |
Why?
|
Posture | 1 | 2015 | 53 | 0.030 |
Why?
|
Systole | 1 | 2015 | 87 | 0.030 |
Why?
|
Diastole | 1 | 2015 | 90 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2017 | 637 | 0.030 |
Why?
|
Neurophysiology | 1 | 2015 | 9 | 0.030 |
Why?
|
Glycerides | 1 | 2015 | 13 | 0.030 |
Why?
|
Electrocardiography | 1 | 2020 | 562 | 0.030 |
Why?
|
Body Composition | 1 | 2017 | 365 | 0.030 |
Why?
|
Ankle Brachial Index | 1 | 2015 | 37 | 0.030 |
Why?
|
Waist Circumference | 1 | 2015 | 89 | 0.030 |
Why?
|
Arachidonic Acids | 1 | 2015 | 23 | 0.030 |
Why?
|
Receptor, Cannabinoid, CB2 | 1 | 2015 | 16 | 0.030 |
Why?
|
Research Design | 1 | 2017 | 286 | 0.030 |
Why?
|
Logistic Models | 1 | 2017 | 727 | 0.030 |
Why?
|
Pyrazoles | 1 | 2015 | 64 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2015 | 99 | 0.030 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2015 | 51 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 248 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2014 | 92 | 0.030 |
Why?
|
Phenanthrolines | 1 | 2013 | 3 | 0.030 |
Why?
|
p-Chloromercuribenzoic Acid | 1 | 2013 | 3 | 0.030 |
Why?
|
Phenylmercuric Acetate | 1 | 2013 | 4 | 0.030 |
Why?
|
Gastrointestinal Diseases | 1 | 2014 | 38 | 0.030 |
Why?
|
Edetic Acid | 1 | 2013 | 8 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 525 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2013 | 84 | 0.030 |
Why?
|
Dopamine | 1 | 2015 | 226 | 0.030 |
Why?
|
Down-Regulation | 1 | 2013 | 143 | 0.030 |
Why?
|
Cyclic N-Oxides | 1 | 2012 | 8 | 0.030 |
Why?
|
Spin Labels | 1 | 2012 | 23 | 0.030 |
Why?
|
Cerebrospinal Fluid | 1 | 2012 | 13 | 0.030 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 18 | 0.030 |
Why?
|
Pediatrics | 1 | 2014 | 132 | 0.030 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2012 | 29 | 0.030 |
Why?
|
Injections | 1 | 2012 | 61 | 0.030 |
Why?
|
Weight Loss | 1 | 2015 | 413 | 0.030 |
Why?
|
Gene Transfer Techniques | 1 | 2012 | 69 | 0.030 |
Why?
|
Chromones | 1 | 2011 | 6 | 0.030 |
Why?
|
Antioxidants | 1 | 2012 | 114 | 0.030 |
Why?
|
Androstadienes | 1 | 2011 | 17 | 0.030 |
Why?
|
Morpholines | 1 | 2011 | 34 | 0.030 |
Why?
|
Gene Expression | 1 | 2013 | 332 | 0.030 |
Why?
|
United States | 1 | 2020 | 3630 | 0.030 |
Why?
|
Rats, Inbred Lew | 1 | 2011 | 116 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2011 | 57 | 0.020 |
Why?
|
Losartan | 1 | 2011 | 68 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2014 | 863 | 0.020 |
Why?
|
Neurochemistry | 1 | 2010 | 3 | 0.020 |
Why?
|
Bradycardia | 1 | 2009 | 15 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2010 | 80 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2010 | 46 | 0.020 |
Why?
|
Probability | 1 | 2009 | 150 | 0.020 |
Why?
|
Blood Pressure Determination | 1 | 2010 | 94 | 0.020 |
Why?
|
Autoradiography | 1 | 2009 | 47 | 0.020 |
Why?
|
Immunoblotting | 1 | 2009 | 50 | 0.020 |
Why?
|
Nitric Oxide Synthase | 1 | 2009 | 36 | 0.020 |
Why?
|
Protein Binding | 1 | 2009 | 199 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2010 | 519 | 0.020 |
Why?
|